IL-31: A new key player in dermatology and beyond

被引：120

作者：

Bagci, Isin Sinem ^{[1
]}

Ruzicka, Thomas ^{[1
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Dept Dermatol & Allergol, Frauenlobstr 9-11, D-80337 Munich, Germany

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2018年 / 141卷 / 03期

关键词：

IL-31; receptors; interleukins; cytokines; pruritus; atopic eczema; ONCOSTATIN-M RECEPTOR; CHRONIC SPONTANEOUS URTICARIA; CLIENT-OWNED DOGS; ATOPIC-DERMATITIS; SERUM IL-31; SIGNAL-TRANSDUCTION; INTERLEUKIN; 31; T-CELLS; LOKIVETMAB ZTS-00103289; MONOCLONAL-ANTIBODY;

D O I：

10.1016/j.jaci.2017.10.045

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

IL-31 is a novel cytokine expressed in many human tissues and involved mainly in T(H)2-weighted inflammation. IL-31 signals through a receptor complex consisting of IL-31 receptor a and oncostatin M receptor b. The available data show that IL-31 is strongly linked with chronic pruritic skin disorders, such as atopic eczema, and represents a novel target for directed drug therapy. Regulation of immune responses and cellular differentiation and proliferation are recently elucidated effects of IL-31, suggesting a more complex and diverse area of effect for this novel cytokine. This review summarizes the current knowledge on IL-31 and its receptors and the involvement of IL-31 in diseases both in human subjects and mouse models.

引用

页码：858 / 866

页数：9

共 86 条

[11] The significance of the levels of IL-4, IL-31 and TLSP in patients with asthma and/or rhinitis [J].

Chai, Ruonan ;

Liu, Beixing ;

Qi, Feifei .

IMMUNOTHERAPY, 2017, 9 (04) :331-337

[12] Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells [J].

Chattopadhyay, Souvik ;

Tracy, Erin ;

Liang, Ping ;

Robledo, Olivier ;

Rose-John, Stefan ;

Baumann, Heinz .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (05) :3014-3026

[13] Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas [J].

Chen, D. R. ;

Chu, C-Y ;

Chen, C-Y ;

Yang, H-C ;

Chiang, Y-Y ;

Lin, T-Y ;

Chiang, I-P ;

Chuang, D-Y ;

Yu, C-C ;

Chow, K-C .

JOURNAL OF PATHOLOGY, 2008, 215 (03) :290-299

[14] Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis [J].

Cheung, Phyllis Fung-Yi ;

Wong, Chun-Kwok ;

Ho, Amy Wing-Yin ;

Hu, Shuiqing ;

Chen, Da-Peng ;

Lam, Christopher Wai-Kei .

INTERNATIONAL IMMUNOLOGY, 2010, 22 (06) :453-467

[15] Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells [J].

Cornelissen, C. ;

Brans, R. ;

Czaja, K. ;

Skazik, C. ;

Marquardt, Y. ;

Zwadlo-Klarwasser, G. ;

Kim, A. ;

Bickers, D. R. ;

Luescher-Firzlaff, J. ;

Luescher, B. ;

Baron, J. M. .

BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (05) :966-975

[16] Signaling by IL-31 and functional consequences [J].

Cornelissen, Christian ;

Luescher-Firzlaff, Juliane ;

Baron, Jens Malte ;

Luescher, Bernhard .

EUROPEAN JOURNAL OF CELL BIOLOGY, 2012, 91 (6-7) :552-566

[17] Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease [J].

Dambacher, Julia ;

Beigel, Florian ;

Seiderer, Julia ;

Haller, Dirk ;

Goeke, Burkhard ;

Auernhammer, Christoph J. ;

Brand, Stephan .

GUT, 2007, 56 (09) :1257-1265

[18] The antiangiogenic role of the pro-inflammatory cytokine interleukin-31 [J].

Davidi, Shiri ;

Fremder, Ella ;

Kan, Tal ;

Raviv, Ziv ;

Timaner, Michael ;

Karin, Nathan ;

Hershkovitz, Dov ;

Arohneim, Ami ;

Shaked, Yuval .

ONCOTARGET, 2017, 8 (10) :16430-16444

[19] Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice [J].

Dillon, SR ;

Sprecher, C ;

Hammond, A ;

Bilsborough, J ;

Rosenfeld-Franklin, M ;

Presnell, SR ;

Haugen, HS ;

Maurer, M ;

Harder, B ;

Johnston, J ;

Bort, S ;

Mudri, S ;

Kuijper, JL ;

Bukowski, T ;

Shea, P ;

Dong, DL ;

Dasovich, M ;

Grant, FJ ;

Lockwood, L ;

Levin, SD ;

LeCiel, C ;

Waggie, K ;

Day, H ;

Topouzis, S ;

Kramer, J ;

Kuestner, R ;

Chen, Z ;

Foster, D ;

Parrish-Novak, J ;

Gross, JA .

NATURE IMMUNOLOGY, 2004, 5 (07) :752-760

[20] GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor [J].

Diveu, C ;

Lelièvre, E ;

Perret, D ;

Lak-Hal, AHL ;

Froger, J ;

Guillet, C ;

Chevalier, S ;

Rousseau, F ;

Wesa, A ;

Preissner, L ;

Chabbert, M ;

Gauchat, JF ;

Galy, A ;

Gascan, H ;

Morel, A .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :49850-49859

← 1 2 3 4 5 6 7 8 9 →